Clinical Trial Update: Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in HER2-positive breast cancer evaluating a chemotherapy-free regimen of trastuzumab and pertuzumab guided by FDG-PET response; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Perjeta (pertuzumab)

Snippet

Sponsor: MedSIR | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING